Skip to content

COVID-19 vaccine booster produces strong responses in people with HIV with low CD4 counts

Professor Dan Barouch at CROI 2022.

Patients who developed advanced HIV in DRC and Kenya ‘slipped through the cracks’ of health and social structures

A patient and staff in the TB ward of Homa Bay Hospital, Kenya, where the study was conducted. TB is the leading cause of death among AIDS patients. Image by Patrick Meinhardt.

Headlines linking people with HIV to COVID variants are at best incomplete, at worst stigmatising

Image: Africa Health Research Institute

High mortality of people living with HIV in Thailand highlights the need for early diagnosis and treatment

Wiraporn Srisuwanwattana, USAID. Creative Commons licence.

CD4 count below 500 or detectable viral load raise the risk of severe COVID-19 for people with HIV

Photo by Gustavo Fring from Pexels

Improved treatment for cryptococcal meningitis, a leading cause of death in people with HIV

Dr David Lawrence (bottom left) presenting to IAS 2021.

Low CD4 cell count linked to increased risk of cancer among people with HIV in South Africa

A vial of blood is resting on a form that indicates it will be tested for CD4 cells. The image has a pink and purple filter over it.

CD4 count below 350 increases the risk of severe COVID-19

Gerd Altmann/Pixabay

Study shows a 70% decline in baseline CD4 testing in Uganda over six years

Image: Leonie Broekstra/Shutterstock.com